Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7L1P19 is a processed pseudogene located in the human genome, designated by the HUGO Gene Nomenclature Committee as RPL7L1 pseudogene 19. Unlike canonical protein-coding genes, RPL7L1P19 does not produce an active protein; it is a non-functional copy of the RPL7L1 gene. Pseudogenes generally arise from gene duplication or retrotransposition events and typically lack functional roles in normal or pathological biological processes. There is no evidence that RPL7L1P19 is expressed or relevant as a therapeutic target. The functional, protein-coding gene in this locus family is RPL7L1 (Ribosomal protein L7 like 1), which is associated with ribosome structure and cancer biology[2][3]; however, RPL7L1P19 has no direct, functional, biological, or disease implications[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPL7L1 pseudogene 19 (RPL7L1P19).